Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase NA 6Phase 4 2Phase 3 2Phase 1/2 2Phase 2/3 1Phase 1 1

Status

Unknown 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1

Conditions

Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Wrist Fractures 1Triple Negative Breast Neoplasms 1Thyroid Diseases 1Stomach Neoplasms 1Portal Vein Tumor Thrombus 1Meningiomas of the Middle Cranial Fossa 1Hand Injuries 1Edema 1Dupuytren Contracture 1Disease 1Adenocarcinoma Of Esophagus 1

Interventions

Dexamethasone 8Oxycodone 6Epoetin Alfa 5Propofol 4Palonosetron 4Meropenem 4Zoledronic Acid 3Vancomycin 3Sevoflurane 3Ondansetron 3Naloxone 3Everolimus 3Ciprofloxacin 3Cholecalciferol 3Ceftazidime 3Cefepime 3Calcium Dobesilate 3Bevacizumab 3Aspirin 3Aprepitant 3peginterferon alfa-2a 2edoxaban 2apixaban 2apatinib 2Vitamin B 12 2Vincristine 2Tobacco Use Cessation Devices 2Teicoplanin 2Tablets 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Neoplasms × Surgical Procedures, Operative × Clear all
NCT00902083 2012-04-09

rAd-p53

Shenzhen SiBiono GeneTech Co.,Ltd

Phase 4 Unknown
600 enrolled
Tumor-Agnostic

Neoplasms

NCT00902122 2012-04-09

rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors

Shenzhen SiBiono GeneTech Co.,Ltd

Phase 4 Unknown
600 enrolled
Head & Neck

Neoplasms, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡